Pain Clinical Trial
— NOUNOURSOfficial title:
Development of a New Pain Rating Scale for Children and Validation Against Criteria by Comparison With Faces Pain Scale - Revised (FPS-R) and Visual Analogue Scale (VAS)
| Verified date | February 2018 |
| Source | Hospices Civils de Lyon |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
In clinical practice with young children, gold standard rating scales used to evaluate the
pain are VAS (Visual Analogue Scale) and FPS-R (Faces Pain Scale - Revised), which are
self-assessment tools. These scales present however certain limitations: the VAS is not
applicable if the child does not know how to estimate the distances, as young children, or
children with mental retardation. As for FPS-R, it can be frightening for children by the
aspect of faces looking like impersonal masks.
For children under 4 years, only hetero-evaluation based on typical behavioral scales as Face
Legs Activity Cry Consolability (FLACC) can be used, according to the current
recommendations.
We thus wanted to create a new faces scale with teddy bear faces, which are cross-cultural
and timeless. Our objective is to validate the new teddy scale in its paper shape on a wide
sample of children. We made the hypothesis that the teddy scale would enable to evaluate the
pain in the same way that the FPS-R, being better accepted and preferred by children.
The first phase of this study will be to develop the teddy scale with a sample of 30 healthy
children from 4 to 11 year-old, having already experienced pain. This stage allows the
validation of the images chosen for the scale, to make sure of their relevance and their
optimal recognition by the children.
The scale will then be validated with a sample of 218 hospitalized children from 2 to 11
years old, to whom pain is usually evaluated in a systematic way. Children from 4 to 11 years
old will have simultaneously the teddy scale, the VAS and the FPS-R. They will be asked to
determine which scale they preferred. Children from 2 to 4 years old will have the teddy
scale; the FLACC will be filled in by parents.
Tested hypothesis: The discriminating characteristic of the teddy scale is superior to that
of the FPS-R scale The validation of the teddy scale will enable to objectify children's
pain, to facilitate the decision-making in the choice of the analgesic to prescribe, and to
check the efficiency of these decisions. This teddy scale could be used in current practice
as a replacement of the FPS-R.
Following this study, we planned to set up a second project in which the teddy scale will be
adapted to electronic form (touchpads), to test its adaptability with the children.
| Status | Completed |
| Enrollment | 70 |
| Est. completion date | July 2017 |
| Est. primary completion date | July 2017 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 2 Years to 11 Years |
| Eligibility |
Inclusion Criteria: - Affiliated with the French healthcare system - Agreed to participate in the study, of which parents/ holders of parental authority signed the informed consent form Scale development phase: - Children aged from 4 to 11 years at inclusion - Having already experienced pain Scale validation phase: - Children aged from 2 to 11 years old at inclusion - Hospitalized in one of the Hôpital Femme-Mère-Enfant (HFME) departments - At risk of presenting pain, that is to whom the pain is usually evaluated in a systematic way Exclusion Criteria: - Children among whom the understanding and/or the language is not sufficient to allow a good comprehension of study instructions - Children participating simultaneously in another interventional research, being able to interfere with the study results |
| Country | Name | City | State |
|---|---|---|---|
| France | Service de Médecine Physique et Réadaptation Pédiatrique - Hôpital Femme-Mère-Enfant | Bron |
| Lead Sponsor | Collaborator |
|---|---|
| Hospices Civils de Lyon |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Pain assessment (4-11 years old) | Children aged 4-11 will be asked to score the pain they feel at that time, using the 3 scales presented in a randomly assigned order. The measure of the correlation between the scores of the 3 pain scales: VAS score (continuing : 0.0 to 10.0), FPS-R score (0,2,4,6,8,10), and teddy scale score (0,2,4,6,8,10) will be evaluated. | Baseline | |
| Secondary | Pain assessment (4-11 years old) depending on age. | Children aged 4-11 will be asked to score the pain they feel at that time, using the 3 scales presented in a randomly assigned order. The measure of discriminating characteristics of each scale (teddy scale, FPS-R and VAS), according to the age (continuing age, or in range: 4-6, 6-8 and 8-11) will be performed. | Baseline | |
| Secondary | Scale preference (4-11 years old) | The 174 patients (aged 4-11 years old) will be asked to choose the scale they preferred between teddy scale, VAS and FPS-R. The number of times where the teddy scale is preferred will be counted (result expressed in percentage) and compared to the 2 other scales. | Baseline | |
| Secondary | Sensibility of change of teddy and FPS-R scales | The sensibility of change (before/after treatment intake) will be measured by the size-effect (mean of the differences divided by the standard deviation before treatment) and by standardized mean responses (mean of the differences divided by the differences standard deviations). | Baseline | |
| Secondary | Pain assessment (2-3 years-old) | Children aged 2-3 years old will be asked to score the pain they feel at that time, using the teddy scale while parents will fill up the FLACC scale. The measure of the correlation between scores of the 2 pain scales: teddy scale score (0,2,4,6,8,10) and FLACC score (continuing from 0 to 10), will be performed using statistical models. | Baseline |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05559255 -
Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI
|
N/A | |
| Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
| Terminated |
NCT04356352 -
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
|
Phase 2/Phase 3 | |
| Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
| Completed |
NCT04466111 -
Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
|
||
| Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
| Completed |
NCT05868122 -
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
|
Phase 3 | |
| Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
| Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
| Enrolling by invitation |
NCT06087432 -
Is PNF Application Effective on Temporomandibular Dysfunction
|
N/A | |
| Completed |
NCT05508594 -
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
| Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
| Completed |
NCT03678168 -
A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries
|
N/A | |
| Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
| Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
| Completed |
NCT02913027 -
Can We Improve the Comfort of Pelvic Exams?
|
N/A | |
| Terminated |
NCT02181387 -
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
|
Phase 4 | |
| Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
| Active, not recruiting |
NCT03613155 -
Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care
|